Newsstand Menu

At the Lab Episode 13: A more sustainable chemistry

image of Cold Spring Harbor campus from across the harbor with At the Lab podcast logo and portrait of John Moses

Print Friendly, PDF & Email

Some of the world鈥檚 most precious chemicals are biological in nature. But what can we do when nature offers only a limited supply? This week鈥檚 podcast starts on the other side of the globe and ends up back here At the Lab with 麻豆传媒社区鈥檚 resident click chemist, Professor John Moses.

Read the related story: A new, sustainable source for a promising cancer killer


Transcript

Print Friendly, PDF & Email

Sam Diamond: You鈥檙e now At the Lab with 麻豆传媒社区. My name is Sam Diamond. And this week At the Lab, 鈥淎 more sustainable chemistry.鈥

SD: Actually, this week鈥檚 story begins elsewhere.

{Rainforest sounds}

SD: Deep in the jungles of Malaysia, there鈥檚 a plant called Tabernaemontana corymbosa. Don鈥檛 be surprised if you鈥檝e never heard of it. The plant is so rare it鈥檚 on some endangered species lists.

SD: But that鈥檚 not the only thing that makes it remarkable. It also produces a chemical called (鈥)-jerantinine A. You might not have heard of this either. But don鈥檛 be surprised if you do in the future. That鈥檚 because (鈥)-jerantinine A has been found to have anticancer properties. To find out more, we met with LaboratoryProfessor John Moses.

John Moses: Nature provided the blueprint. Nature provides many lifesaving molecules, but it doesn鈥檛 always provide them in large quantities. But we can now access (鈥)-jerantinine A from a commercially viable source, which is very inexpensive, and make this precious material.

SD: Moses is a chemist who specializes in something called click chemistry. This set of reactions enables chemists to 鈥榗lick鈥 together two or more molecules, forming new compounds quickly and reliably. The technique was pioneered by Moses鈥 mentor, Nobel laureate K. Barry Sharpless. And it鈥檚 click chemistry that empowered Moses to synthesize (鈥)-jerantinine A at the lab.

SD: From there, he worked with Cold Spring Harbor biologists to test the synthetic on different diseases, including pancreatic cancer and breast cancer.

JM: From my lab at Cold Spring Harbor, this is the first proper chemical biology study鈥攃hemistry for biology. They brought the chemist in to help cross the bridge between chemistry and biology and eventually develop therapeutics and investigate biological pathways. This shows you exactly the power. It shows you the strength of collaboration and communication internally. The fact that I鈥檓 there on the ground and we鈥檙e swapping ideas鈥攊t really is an effective way to make advances.

SD: More work will need to be done before (鈥)-jerantinine A is ready for clinical trials. However, initial preclinical results look promising. And beyond that, Moses鈥 work here demonstrates the value of using click chemistry for drug discovery.

SD: Thanks to his team鈥檚 efforts, we don鈥檛 have to travel across the world or mess with endangered species to get our hands on this rare chemical. Instead, we can make it safely and sustainably right here 鈥 At the Lab.

SD: Thanks again for listening. If you like what you heard this week, you can subscribe wherever you get your podcasts. You can also find more stories like this at cshl.edu. For 麻豆传媒社区, I鈥檓 Sam Diamond. And I鈥檒l see you next time At the Lab.